User profiles for D Vena

Daniel Vena

Harvard Medical School, Brigham and Women's Hospital
Verified email at bwh.harvard.edu
Cited by 998

Neurotoxicity of purine analogs: a review.

BD Cheson, DA Vena, FM Foss… - Journal of Clinical …, 1994 - ascopubs.org
PURPOSE The purine analogs, fludarabine, cladribine, and pentostatin, are active against
a broad spectrum of indolent lymphoid malignancies. They also have similar toxicities, …

[HTML][HTML] gp100 peptide vaccine and interleukin-2 in patients with advanced melanoma

…, SA Rosenberg, P Choyke, D Vena… - … England Journal of …, 2011 - Mass Medical Soc
Background Stimulating an immune response against cancer with the use of vaccines remains
a challenge. We hypothesized that combining a melanoma vaccine with interleukin-2, an …

[HTML][HTML] Treatment of anal high-grade squamous intraepithelial lesions to prevent anal cancer

…, A Arons, JC Pugliese, D Vena… - New England journal …, 2022 - Mass Medical Soc
Background The incidence of anal cancer is substantially higher among persons living with
the human immunodeficiency virus (HIV) than in the general population. Similar to cervical …

Measuring response in solid tumors: unidimensional versus bidimensional measurement

…, M Christian, M Terenziani, D Vena… - Journal of the …, 1999 - academic.oup.com
BACKGROUND: Tumor shrinkage is a common end point used in screening new cytotoxic
agents. The standard World Health Organization criterion for partial response is a 50% or …

Secondary leukemia or myelodysplastic syndrome after treatment with epipodophyllotoxins

…, VJ Land, J Miser, J Shuster, D Vena - Journal of Clinical …, 1999 - ascopubs.org
PURPOSE: The incidence of secondary leukemia after epipodophyllotoxin treatment and
the relationship between epipodophyllotoxin cumulative dose and risk are not well …

Paclitaxel for platinum-refractory ovarian cancer: results from the first 1,000 patients registered to National Cancer Institute Treatment Referral Center 9103.

EL Trimble, JD Adams, D Vena, MJ Hawkins… - Journal of clinical …, 1993 - ascopubs.org
PURPOSE To provide an investigational drug, paclitaxel, now commercially available, to
women with refractory ovarian cancer and to evaluate response and toxicity in these patients. …

Gait analysis in orthopedic foot and ankle surgery—topical review, part 1: principles and uses of gait analysis

DJ Mayich, A Novak, D Vena… - Foot & ankle …, 2014 - journals.sagepub.com
Gait analysis, the systematic study of human walking, is a field that has been studied for well
over 100 years. With the technological and scientific advancements of the last several …

Risk factors for osteonecrosis of the jaws: a case-control study from the CONDOR dental PBRN

…, FA Curro, P Hujoel, AH Sung, D Vena… - Journal of dental …, 2011 - journals.sagepub.com
Case reports and cohort studies have linked bisphosphonate therapy and osteonecrosis of
the jaws (ONJ), but neither causality nor specific risks for lesion development have been …

The sleep apnea–specific pulse-rate response predicts cardiovascular morbidity and mortality

…, L Taranto-Montemurro, T Sofer, D Vena… - American journal of …, 2021 - atsjournals.org
Rationale: Randomized controlled trials have been unable to detect a cardiovascular benefit
of continuous positive airway pressure in unselected patients with obstructive sleep apnea (…

Second malignancies as a consequence of nucleoside analog therapy for chronic lymphoid leukemias

BD Cheson, DA Vena, J Barrett… - Journal of Clinical …, 1999 - ascopubs.org
PURPOSE: The nucleoside analogs fludarabine, 2′-deoxycoformycin (DCF), and 2-chlorodeoxyadenosine
(CdA), commonly used in the treatment of patients with indolent lymphoid …